03 Jul 2024 --- Scientists at the US National Institute of Allergy and Infectious Diseases (NIAID) say Roseomonas mucosa, a naturally occurring bacterium on healthy skin, can effectively treat eczema in adults and children. That has led to the development of Defensin by Skinesa, a new over-the-counter topical probiotic for eczema. Dr. Ian Myles, MD, MPH, principal investigator of the Epithelial Therapeutics Unit at the NIAID, tells Personal Care Insights, the development represents a “milestone” for eczema sufferers and is the result of seven years of research at NIAID’s Laboratory of Clinical Immunology and Microbiology (LCIM):
